Carisma Therapeutics Statistics

Total Valuation

CARM has a market cap or net worth of $8.02 million. The enterprise value is -$8.33 million.

Market Cap	8.02M
Enterprise Value	-8.33M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CARM has 41.79 million shares outstanding. The number of shares has increased by 23.66% in one year.

Current Share Class	41.79M
Shares Outstanding	41.79M
Shares Change (YoY)	+23.66%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	23.16%
Float	30.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.41
Forward PS	0.47
PB Ratio	-0.29
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.48

Current Ratio	1.48
Quick Ratio	1.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-62.68%
Return on Invested Capital (ROIC)	-1,779.60%
Return on Capital Employed (ROCE)	-417.82%
Revenue Per Employee	$426,783
Profits Per Employee	-$1.31M
Employee Count	46
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.24% in the last 52 weeks. The beta is 2.79, so CARM's price volatility has been higher than the market average.

Beta (5Y)	2.79
52-Week Price Change	-88.24%
50-Day Moving Average	0.36
200-Day Moving Average	0.75
Relative Strength Index (RSI)	28.48
Average Volume (20 Days)	270,970

Short Selling Information

The latest short interest is 484,882, so 1.16% of the outstanding shares have been sold short.

Short Interest	484,882
Short Previous Month	427,139
Short % of Shares Out	1.16%
Short % of Float	1.60%
Short Ratio (days to cover)	3.11

Income Statement

In the last 12 months, CARM had revenue of $19.63 million and -$60.48 million in losses. Loss per share was -$1.46.

Revenue	19.63M
Gross Profit	-40.04M
Operating Income	-60.18M
Pretax Income	-72.70M
Net Income	-60.48M
EBITDA	-56.83M
EBIT	-60.18M
Loss Per Share	-$1.46

Full Income Statement

Balance Sheet

The company has $18.83 million in cash and $2.48 million in debt, giving a net cash position of $16.35 million or $0.39 per share.

Cash & Cash Equivalents	18.83M
Total Debt	2.48M
Net Cash	16.35M
Net Cash Per Share	$0.39
Equity (Book Value)	-27.91M
Book Value Per Share	-0.67
Working Capital	7.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.92 million and capital expenditures -$123,000, giving a free cash flow of -$60.04 million.

Operating Cash Flow	-59.92M
Capital Expenditures	-123,000
Free Cash Flow	-60.04M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross Margin	-203.96%
Operating Margin	-306.54%
Pretax Margin	-308.05%
Profit Margin	n/a
EBITDA Margin	-289.45%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CARM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.66%
Shareholder Yield	n/a
Earnings Yield	-753.77%
FCF Yield	-748.32%

Dividend Details

Analyst Forecast

The average price target for CARM is $0.90, which is 350.00% higher than the current price. The consensus rating is "Hold".

Price Target	$0.90
Price Target Difference	350.00%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-19.28%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARM has an Altman Z-Score of -19.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.01
Piotroski F-Score	3